TELA Bio (TELA) Short term Debt (2025)
TELA Bio (TELA) posted Short term Debt of $3.3 million for Q2 2025.
Powered by 
Analysis
TELA Bio (TELA) Short term Debt (2025) Analysis & Trends
TELA Bio has reported Short term Debt for 1 years, with the latest figure at $3.3 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | TELA Bio | 49.54 Mn | 19.12 Mn | 13.94 Mn |